Literature DB >> 25692240

Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain.

Noa Liscovitch1, Lily Bazak, Erez Y Levanon, Gal Chechik.   

Abstract

A-to-I RNA editing by adenosine deaminases acting on RNA is a post-transcriptional modification that is crucial for normal life and development in vertebrates. RNA editing has been shown to be very abundant in the human transcriptome, specifically at the primate-specific Alu elements. The functional role of this wide-spread effect is still not clear; it is believed that editing of transcripts is a mechanism for their down-regulation via processes such as nuclear retention or RNA degradation. Here we combine 2 neural gene expression datasets with genome-level editing information to examine the relation between the expression of ADAR genes with the expression of their target genes. Specifically, we computed the spatial correlation across structures of post-mortem human brains between ADAR and a large set of targets that were found to be edited in their Alu repeats. Surprisingly, we found that a large fraction of the edited genes are positively correlated with ADAR, opposing the assumption that editing would reduce expression. When considering the correlations between ADAR and its targets over development, 2 gene subsets emerge, positively correlated and negatively correlated with ADAR expression. Specifically, in embryonic time points, ADAR is positively correlated with many genes related to RNA processing and regulation of gene expression. These findings imply that the suggested mechanism of regulation of expression by editing is probably not a global one; ADAR expression does not have a genome wide effect reducing the expression of editing targets. It is possible, however, that RNA editing by ADAR in non-coding regions of the gene might be a part of a more complex expression regulation mechanism.

Entities:  

Keywords:  A-to-I RNA editing; ADAR; Alu elements; Transcriptome; brain; brain development; co-expression; expression regulation

Mesh:

Substances:

Year:  2014        PMID: 25692240      PMCID: PMC4615195          DOI: 10.4161/15476286.2014.992286

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  69 in total

1.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.

Authors:  M Higuchi; S Maas; F N Single; J Hartner; A Rozov; N Burnashev; D Feldmeyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

2.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.

Authors:  Leilei Chen; Yan Li; Chi Ho Lin; Tim Hon Man Chan; Raymond Kwok Kei Chow; Yangyang Song; Ming Liu; Yun-Fei Yuan; Li Fu; Kar Lok Kong; Lihua Qi; Yan Li; Na Zhang; Amy Hin Yan Tong; Dora Lai-Wan Kwong; Kwan Man; Chung Mau Lo; Si Lok; Daniel G Tenen; Xin-Yuan Guan
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

3.  Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates.

Authors:  Nurit Paz-Yaacov; Erez Y Levanon; Eviatar Nevo; Yaron Kinar; Alon Harmelin; Jasmine Jacob-Hirsch; Ninette Amariglio; Eli Eisenberg; Gideon Rechavi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 4.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

5.  Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.

Authors:  Alfonso Lavado; Yu He; Joshua Paré; Geoffrey Neale; Eric N Olson; Marco Giovannini; Xinwei Cao
Journal:  Development       Date:  2013-07-17       Impact factor: 6.868

6.  The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus.

Authors:  Lily Agranat; Oleg Raitskin; Joseph Sperling; Ruth Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

7.  Spatio-temporal transcriptome of the human brain.

Authors:  Hyo Jung Kang; Yuka Imamura Kawasawa; Feng Cheng; Ying Zhu; Xuming Xu; Mingfeng Li; André M M Sousa; Mihovil Pletikos; Kyle A Meyer; Goran Sedmak; Tobias Guennel; Yurae Shin; Matthew B Johnson; Zeljka Krsnik; Simone Mayer; Sofia Fertuzinhos; Sheila Umlauf; Steven N Lisgo; Alexander Vortmeyer; Daniel R Weinberger; Shrikant Mane; Thomas M Hyde; Anita Huttner; Mark Reimers; Joel E Kleinman; Nenad Sestan
Journal:  Nature       Date:  2011-10-26       Impact factor: 49.962

8.  GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists.

Authors:  Eran Eden; Roy Navon; Israel Steinfeld; Doron Lipson; Zohar Yakhini
Journal:  BMC Bioinformatics       Date:  2009-02-03       Impact factor: 3.169

9.  Inosine-containing dsRNA binds a stress-granule-like complex and downregulates gene expression in trans.

Authors:  A D J Scadden
Journal:  Mol Cell       Date:  2007-11-09       Impact factor: 17.970

10.  Evidence for large diversity in the human transcriptome created by Alu RNA editing.

Authors:  Michal Barak; Erez Y Levanon; Eli Eisenberg; Nurit Paz; Gideon Rechavi; George M Church; Ramit Mehr
Journal:  Nucleic Acids Res       Date:  2009-09-08       Impact factor: 16.971

View more
  10 in total

1.  ADARB1 catalyzes circadian A-to-I editing and regulates RNA rhythm.

Authors:  Hideki Terajima; Hikari Yoshitane; Haruka Ozaki; Yutaka Suzuki; Shigeki Shimba; Shinya Kuroda; Wataru Iwasaki; Yoshitaka Fukada
Journal:  Nat Genet       Date:  2016-11-28       Impact factor: 38.330

Review 2.  A-to-I RNA editing - thinking beyond the single nucleotide.

Authors:  Nabeel S Ganem; Ayelet T Lamm
Journal:  RNA Biol       Date:  2017-10-11       Impact factor: 4.652

Review 3.  To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.

Authors:  Emily A Erdmann; Ananya Mahapatra; Priyanka Mukherjee; Boyoon Yang; Heather A Hundley
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-12-27       Impact factor: 8.250

4.  Effects of social isolation and re-socialization on cognition and ADAR1 (p110) expression in mice.

Authors:  Wei Chen; Dong An; Hong Xu; Xiaoxin Cheng; Shiwei Wang; Weizhi Yu; Deqin Yu; Dan Zhao; Yiping Sun; Wuguo Deng; Yiyuan Tang; Shengming Yin
Journal:  PeerJ       Date:  2016-08-18       Impact factor: 2.984

Review 5.  Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease.

Authors:  Peter A Larsen; Kelsie E Hunnicutt; Roxanne J Larsen; Anne D Yoder; Ann M Saunders
Journal:  Chromosome Res       Date:  2018-02-19       Impact factor: 5.239

6.  Structure-mediated modulation of mRNA abundance by A-to-I editing.

Authors:  Anneke Brümmer; Yun Yang; Tracey W Chan; Xinshu Xiao
Journal:  Nat Commun       Date:  2017-11-02       Impact factor: 14.919

7.  Inverted repeat structures are associated with essential and highly expressed genes on C. elegans autosome distal arms.

Authors:  Daniel P Reich; Brenda L Bass
Journal:  RNA       Date:  2018-09-06       Impact factor: 4.942

8.  Automated Isoform Diversity Detector (AIDD): a pipeline for investigating transcriptome diversity of RNA-seq data.

Authors:  Noel-Marie Plonski; Emily Johnson; Madeline Frederick; Heather Mercer; Gail Fraizer; Richard Meindl; Gemma Casadesus; Helen Piontkivska
Journal:  BMC Bioinformatics       Date:  2020-12-30       Impact factor: 3.169

9.  ADARs act as potent regulators of circular transcriptome in cancer.

Authors:  Haoqing Shen; Omer An; Xi Ren; Yangyang Song; Sze Jing Tang; Xin-Yu Ke; Jian Han; Daryl Jin Tai Tay; Vanessa Hui En Ng; Fernando Bellido Molias; Priyankaa Pitcheshwar; Ka Wai Leong; Ker-Kan Tan; Henry Yang; Leilei Chen
Journal:  Nat Commun       Date:  2022-03-21       Impact factor: 14.919

10.  ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.

Authors:  Eduardo A Sagredo; Alejandro Blanco; Alfredo I Sagredo; Paola Pérez; Gonzalo Sepúlveda-Hermosilla; Fernanda Morales; Bettina Müller; Ricardo Verdugo; Katherine Marcelain; Olivier Harismendy; Ricardo Armisén
Journal:  Biol Res       Date:  2018-10-05       Impact factor: 5.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.